AVADEL PHARMACEUTICALS PLC

About AVADEL PHARMACEUTICALS PLC

Avadel Pharmaceuticals plc is a biopharmaceutical company specializing in developing and commercializing treatments for rare central nervous system disorders. Its core product, LUMRYZ, is an extended-release sodium oxybate formulation for narcolepsy-related cataplexy and excessive daytime sleepiness in patients aged seven and older. Avadel leverages proprietary drug delivery technologies and operates primarily in the U.S. market, focusing on improving patient compliance and safety through innovative dosing regimens and regulatory exclusivities.